Abu Dhabi bourse operator expects trio of dual listings

The Abu Dhabi Securities Exchange (ADX) is reported to expect dual listings of up to three companies during the rest of this year.

The businesses, in the technology and healthcare sectors, are working to finalise regulatory approval procedures in their home markets, ADX chief executive Abdulla Al Nuaimi told Asharq Business.

In September 2025 the ADX signed an agreement with Hong Kong Exchanges and Clearing Limited to deepen co-operation by exploring dual listings, cross-border financing and mechanisms to facilitate investment.

In May Bloomberg reported that Hong Kong-listed Insilico Medicine Cayman TopCo was planning a secondary listing in Abu Dhabi.

Al Nuaimi said the ADX is expanding its investment products, with a focus on exchange-traded funds.

The exchange intends to double the number of derivatives contracts to 20, Al Nuaimi said. It launched a derivatives market in November 2021 to develop the emirate’s capital markets.

ADX said it would lead a delegation of 23 listed companies to a conference in London from June 8 to 11 to showcase Abu Dhabi’s growth prospects.

In the first quarter of 2026 ADX-listed companies reported AED48 billion ($13 billion) in profits, up 17 percent year on year. The companies have announced AED66 billion in dividends so far this year.

Foreign investors accounted for more than 47 percent of total trading value during the first four months of 2026, amounting to AED111 billion.

Further reading:

• Saudi IPO woes continue as contractor withdraws offering
• Gulf funds balance SpaceX potential against AI cash burn
• First Saudi IPO since Iran war set to raise $55m